Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 2958-2968

  Lovitch, Scott B ^a   Pu, Zheng ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; H2 DM ANTIGEN; HLA DM ANTIGEN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; PROTEIN I A KAPPA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; ENDOSOME; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 33644550942     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.2958     Document Type: Article

References (51)

1. Nelson, C. A., and D. H. Fremont. 1999. Structural principles of MHC class II antigen presentation. Rev. Immunogenet. 1: 47-59.
2. Unanue, E. R. 2002. Perspective on antigen processing and presentation. Immunol. Rev. 185: 86-102.
3. Viner, N. J., C. A. Nelson, B. Deck, and E. R. Unanue. 1996. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156: 2365-2368.
4. k-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. Proc. Natl. Acad. Sci. USA 92: 2214-2218.
5. Gyotoku, T., Y. Fukui, and T. Sasazuki. 1998. An endogenously processed self peptide and the corresponding exogenous peptide bound to the same MHC class II molecule could be distinct ligands for TCR with different kinetic stability. Eur. J. Immunol. 28: 4050-4061.
6. Viret, C., X. He, and C. A. Janeway, Jr. 2003. Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection. Proc. Natl. Acad. Sci. USA 100: 5354-5359.
7. Schmitt, L., J. J. Boniface, M. M. Davis, and H. M. McConnell. 1999. Conformational isomers of a class II MHC-peptide complex in solution. J. Mol. Biol. 286: 207-218.
8. u conformers in murine experimental autoimmune encephalomyelitis. J. Immunol. 171: 2467-2477.
9. Peterson, D. A., R. J. DiPaolo, O. Kanagawa, and E. R. Unanue. 1999. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11: 453-462.
10. k-derived peptides that are autoantigenic to type B T cells. J. Immunol. 370: 4155-4160.
11. Pu, Z., J. A. Carrero, and E. R. Unanue. 2002. Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 99: 8844-8849.
12. Pu, Z., S. B. Lovitch, E. K. Bikoff, and E. R. Unanue. 2004. T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 20: 467-476.
13. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82: 155-165.
14. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3: 197-205.
15. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806.
16. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274: 618-620.
17. Vogt, A. B., H. Kropshofer, G. Moldenhauer, and G. J. Hammerling. 1996. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl. Acad. Sci. USA 93: 9724-9729.
18. van Ham, S. M., U. Gruneberg, G. Malcherek, I. Broker, A. Melms, and J. Trowsdale. 1996. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184: 2019-2024.
19. Kropshofer, H., A. B. Vogt, G. Moldenhauer, J. Hammer, J. S. Blum, and G. J. Hammerling. 1996. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15: 6144-6154.
20. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184: 2153-2165.
21. Kropshofer, H., S. O. Aradt, G. Moldenhauer, G. J. Hammerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6: 293-302.
22. Zarutskie, J. A., R. Busch, Z. Zavala-Ruiz, M. Rushe, E. D. Mellins, and L. J. Stern. 2001. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc. Natl. Acad. Sci. USA 98: 12450-12455.
23. Doebele, R. C., R. Busch, H. M. Scott, A. Pashine, and E. D. Mellins. 2000. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13: 517-527.
24. Pashine, A., R. Busch, M. P. Belmares, J. N. Munning, R. C. Doebele, M. Buckingham, G. P. Nolan, and E. D. Mellins. 2003. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 19: 183-192.
25. Belmares, M. P., R. Busch, K. W. Wucherpfennig, H. M. McConnell, and E. D. Mellins. 2002. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes. J. Immunol. 169: 5109-5117.
26. Stratikos, E., L. Mosyak, D. M. Zaller, and D. C. Wiley. 2002. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DRI by formation of tethered complexes that present enhanced HLA-DM catalysis. J. Exp. Med. 196: 173-183.
27. Stratikos, E., D. C. Wiley, and L. J. Stern. 2004. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II α-chain. J. Immunol. 172: 1109-1117.
28. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. USA 90: 1227-1231.
29. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371: 250-252.
30. k in complex with a dominant epitope of lysozyme. Immunity 8: 305-317.
31. Koonce, C. H., G. Wutz, E. J. Robertson, A. B. Vogt, H. Kiopshofer, and E. K. Bikoff. 2003. DM loss in k haplotype mice reveals isotype-specific chaperone requirements. J. Immunol. 170: 3751-3761.
32. McConahey, P. J., and F. J. Dixon. 1980. Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol. 70: 210-213.
33. Harding, C. V., D. S. Collins, J. W. Slot, H. J. Geuze, and E. R. Unanue. 1991. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64: 393-401.
34. k. J. Immunol. 157: 755-762.
35. Connor, J., M. B. Yatvin, and L. Huang. 1984. pH-sensitive liposomes: acid-induced liposome fusion. Proc. Natl. Acad. Sci. USA 81: 1715-1718.
36. Collins, D. S., K. Findlay, and C. V. Harding. 1992. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J. Immunol. 148: 3336-3341.
37. McFarland, B. J., and C. Beeson. 2002. Binding interactions between peptides and proteins of the class II major histocompatibility complex. Med. Res. Rev. 22: 168-203.
38. McFarland, B. J., J. F. Katz, C. Beeson, and A. J. Sant. 2001. Energetic asymmetry among hydrogen bonds in MHC class II-peptide complexes. Proc. Natl. Acad. Sci. USA 98: 9231-9236.
39. Ceman, S., S. Wu, T. S. Jardetzky, and A. J. Sant. 1998. Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J. Exp. Med. 188: 2139-2149.
40. McFarland, B. J., C. Beeson, and A. J. Sant. 1999. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. J. Immunol 163: 3567-3571.
41. Arneson, L. S., J. F. Katz, M. Liu, and A. J. Sant. 2001. Hydrogen bond integrity between MHC class II molecules and bound peptide determines the intracellular fate of MHC class II molecules. J. Immunol. 167: 6939-6946.
42. Wilson, N., D. Fremont, P. Marrack, and J. Kappler. 2001. Mutations changing the kinetics of class II MHC peptide exchange. Immunity 5: 513-522.
43. Falk, K., J. M. Lau, L. Santambrogio, V. M. Esteban, F. Puentes, O. Rotzschke, and J. L. Strominger. 2002. Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules. J. Biol. Chem. 277: 2709-2715.
44. Marin-Esteban, V., K. Falk, and O. Rotzschke. 2004. "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J. Biol. Chem. 279: 50684-50690.
45. Carrasco-Marin, E., S. Petzold, and E. R. Unanue. 1999. Two structural states of complexes of peptide and class II major histocompatibility complex revealed by photoaffinity-labeled peptides. J. Biol. Chem. 274: 31333-31340.
46. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375: 603-606.
47. Lindner, R., and E. R. Unanue. 1996. Distinct antigen-MHC class II complexes generated by separate processing pathways. EMBO J. 15: 6910-6920.
48. Griffin, J. P., R. Chu, and C. V. Harding. 1997. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158: 1523-1532.
49. Santambrogio, L., A. K. Sato, G. J. Carven, S. L. Belyanskaya, J. L. Strominger, and L. J. Stern. 1999. Extracellular antigen processing and presentation by immature dendritic cells. Proc. Natl. Acad. Sci. USA 96: 15056-15061.
50. Potter, N. S., and C. V. Harding. 2001. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J. Immunol. 167: 2538-2546.
51. Nelson, C. A., I. Vidavsky, N. J. Viner, M. L. Gross, and E. R. Unanue. 1997. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 94: 628-633.